198 related articles for article (PubMed ID: 26950155)
1. Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.
El-Gewely MR; Andreassen M; Walquist M; Ursvik A; Knutsen E; Nystad M; Coucheron DH; Myrmel KS; Hennig R; Johansen SD
Cancers (Basel); 2016 Mar; 8(3):. PubMed ID: 26950155
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.
Kober P; Mossakowska BJ; Rusetska N; Baluszek S; Grecka E; Konopiński R; Matyja E; Oziębło A; Mandat T; Bujko M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686289
[TBL] [Abstract][Full Text] [Related]
3. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
Foiani G; Guelfi G; Mandara MT
J Neuropathol Exp Neurol; 2021 Sep; 80(8):769-775. PubMed ID: 34272938
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations in meningiomas.
Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
[TBL] [Abstract][Full Text] [Related]
6. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
7. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
[TBL] [Abstract][Full Text] [Related]
8. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.
Choi KH; Shin CH; Lee WJ; Ji H; Kim HH
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974
[TBL] [Abstract][Full Text] [Related]
9. GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma.
Negroni C; Hilton DA; Ercolano E; Adams CL; Kurian KM; Baiz D; Hanemann CO
EBioMedicine; 2020 Sep; 59():102941. PubMed ID: 32810829
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
Song B; Du J; Song DF; Ren JC; Feng Y
Biol Res; 2018 Nov; 51(1):44. PubMed ID: 30390708
[TBL] [Abstract][Full Text] [Related]
11. miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.
Zhang J; Liu Z; Dong Y
Dis Markers; 2022; 2022():6423237. PubMed ID: 35818586
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma.
Eraky AM
Cureus; 2023 Feb; 15(2):e34593. PubMed ID: 36883085
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling in intraocular medulloepitheliomas.
Edward DP; Alkatan H; Rafiq Q; Eberhart C; Al Mesfer S; Ghazi N; Al Safieh L; Kondkar AA; Abu Amero KK
PLoS One; 2015; 10(3):e0121706. PubMed ID: 25807141
[TBL] [Abstract][Full Text] [Related]
15. RT-qPCR Expression Profiles of Selected Oncogenic and Oncosuppressor miRNAs in Formalin-Fixed, Paraffin-Embedded Canine Mammary Tumors.
Abbate JM; Giannetto A; Arfuso F; Brunetti B; Lanteri G
Animals (Basel); 2022 Oct; 12(21):. PubMed ID: 36359024
[TBL] [Abstract][Full Text] [Related]
16. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
17. The Role of MicroRNA 181d as a Possible Biomarker Associated With Tumor Progression in Meningiomas.
Carneiro V; Cirino M; Panepucci R; Peria F; Tirapelli D; Colli B; Carlotti CG
Cureus; 2021 Oct; 13(10):e19158. PubMed ID: 34873501
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer.
Chang KH; Mestdagh P; Vandesompele J; Kerin MJ; Miller N
BMC Cancer; 2010 Apr; 10():173. PubMed ID: 20429937
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation.
Erkan EP; Ströbel T; Dorfer C; Sonntagbauer M; Weinhäusel A; Saydam N; Saydam O
Front Oncol; 2019; 9():1031. PubMed ID: 31649887
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
